Blackstone puts $400M into Teva, Sanofi gut disease drug
Blackstone puts $400M into Teva, Sanofi gut disease drug
Contenido no disponible. Consulta la fuente original.
Blackstone puts $400M into Teva, Sanofi gut disease drug
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.